News

Females were disproportionately affected by some of the restrictions put in place in the early stages of the COVID-19 pandemic.

methylnaltrexone is more effective, less costly, and can even keep some patients out of the hospital after being treated for opioid-induced constipation in the emergency department.

A group of experts discuss new and emerging therapies for IBD.

Double board certified dermatologist Dr. Karan Lal details targeted therapies and surgical treatments for vitiligo and how the condition is perceived by different cultures.

Patients from the lowest BMI, HbA1c, SBP, and LDL-C population quartile had 3.9, 3.8, 1.9, and 0.9 years of additional life expectancy, respectively.

There are several emerging treatments for C difficile infections.

Data show visual display terminal use causes dry eye disease mainly through impaired blinking patterns.

The 2022 State of the Air report from the American Lung Association highlights growing disparities in coastal-based ozone and particle pollution, amid wildfires and shifts in regulatory policies.

The VersiPD Cycler System is expected to be available in the US in 2022.

The company reported interim results at a meeting this week showing multiple formulations were tolerable and safe. Next comes a phase 2 trial.

The estimated annual progression rate to diabetes in older adults with HbA1c-defined prediabetes was 5.3%.

The long-term efficacy of fundoplication surgery has not previously been explored for the management of the symptoms of GERD.

Individuals in the intervention arm walked a mean of 647 more steps per day compared with the control arm.

A new method of opioid disposal was proposed by the FDA in an attempt to mitigate unauthorized access to opioids and lessen risk of addiction.

Investigators hypothesize that the development of culturally tailored interventions could prove beneficial for engaging racial and ethnic minority patients with data-driven insomnia treatment.

Dr. Brett King returns to discuss the impact of JAK inhibitors in the management of atopic dermatitis.

A large proportions of patients with C difficile infections do not respond to metronidazole.

Pregnant women with preexisting T1D or T2D had a higher rate of any DR and a higher DR progression rate compared to the nonpregnant population.

After adjustment for age and sex, data show the reduction in mortality rates in the patients receiving dialysis was greater than the general population.

New data suggests that symptoms of depression are screened in addition to symptoms of insomnia in affected patients.

About 1 in 5 recent novel drug approvals were based on data extrapolated to a broader patient population or in regard to a concomitant drug use, including the controversial aducanumab indication from 2021.

Acadia Pharmaceuticals evaluated the effects of its novel redox modulator drug on pain intensity levels of patients undergoing a bunionectomy.

Dr. Sarah Asch details therapeutic strategies for treating pediatric patients with vitiligo.

Patients with inflammatory bowel disease are at an increased risk of developing depression.

However, initially observed eyes were found more at risk of developing moderate visual loss and more than 80% required treatment over 24 months.

Students who reported maltreatment had 2.47 times the odds of receiving an insomnia diagnosis than those without adverse childhood experiences.

Bianca K. Frogner, PhD, discusses the prevalence of burnout and job dissatisfaction observed across various health care worker roles and settings.

New research shows diarrhea did not increase overall mortality for hospitalized patients.